ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER joins HTAi Policy Forum |
|
The Institute for Clinical and Economic Review (ICER) has been extended an invitation for membership in the Health Technology Assessment International Policy (HTAi) Forum as a not for-profit organizational member. As a member, ICER will take part in the HTAi Policy Forum meeting on Managed Entry Schemes, to be held on January 31 - February 2, 2010 in Washington, D.C. |